ABSTRACT -This study aimed to investigate in a population of Brazilian patients with multiple sclerosis (MS) single-nucleotide polymorphisms (SNP) in the promoter region of IL4 (*33C-T) and receptor IL4R (*Q551R A-G) genes proposed to interfere with disease progression. No significant differences were observed in either of the SNPs investigated between healthy controls (n=135) and MS patients (n=129). However, the IL4+33 TT genotype was significantly (p=0.039) higher in African descendants MS (AF-MS= 9.09%) than in Caucasian MS (CA-MS= 1.35%). It was also observed a significant (p=0.016) increase for the IL4R* Q551R CC genotype in AF-MS compared to those of Caucasian ethnicity (AF-MS= 21.62%; CA-MS= 4.35%). These results suggest that IL4+33 and IL4R*Q551 polymorphisms may have a disease-promoting role of TH2 mediators in African MS descendants. Additionally neither IL4 nor IL4R genes are susceptibility factors for Brazilian MS but may be able to modify ethnicity-dependent disease risk and penetrance of susceptibility factors.
RESUMO -Este é um estudo inédito realizado numa população brasileira de pacientes portadores de esclerose múltipla (EM) visando determinar uma possível associação na expressão de polimorfismo (SNP) nos genes da citocina reguladora IL4 (*33C-T) e do seu respectivo receptor IL4R (*Q551R A-G) capazes de modificar a evolução da doença. Não foi observada diferença significativa em ambos SNPs analisados entre o grupo controle de indivíduos saudáveis (n=135) e os pacientes com EM (n=129). Contudo, o genotipo IL4+33
TT apresentava percentual mais elevado (9,09%) nos pacientes EM com descendência africana (AF-EM) do que nos descendentes caucasianos (CA-EM=1,35%) sendo esta diferença significativa (p=0,039). Também foi observado um aumento significativo (p=0,016) para o genotipo IL4R* Q551R CC nos pacientes AF-EM (21,62%) comparando-se com CA-EM (4,35%). Estes resultados indicam que polimorfismos nos genes da citocina IL4 (*33C-T) e respectivo receptor IL4R (*Q551R A-G) influenciam na produção de citocinas do tipo TH2 e evolução da doença nos pacientes EM com descendência africana. Embora polimorfismo nos genes IL4 (*33C-T) e respectivo receptor IL4R (*Q551R A-G) não sejam fatores indutores de susceptibilidade para EM podem modificar o risco e evolução da EM numa população com alto grau de miscigenação étnica.
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Multiple sclerosis (MS) is a complex genetic inflammatory demyelinating disease of the central nervous system in which an immune response mediated by T lymphocytes of TH1 subset contribute to the pathogenesis of the disease 1 . Predisposition to MS is influenced by a complex, yet unclear interaction of genetic and environmental factors. Although HLA and especially the allele DQB1*0602 contribute to the overall susceptibility in different ethnic groups and especially Caucasians, other MHC and non-MHC genes with individually epistatic effect may influence demographic characteristic, clinical form and severity of the disease [2] [3] [4] . Microarray experiments using tissue from MS lesions have shown the association of several cytokines with central nervous system (CNS) inflammation 5, 6 . A shift from a CD4+ TH1 pro-inflammatory phenotype to TH2 pattern that is observed during disease remission 7 may result in down-regulation of the immune response via production of antiinflammatory/regulatory cytokines as interleukin 4 (IL-4), IL-10 or bystander suppression 8 . The IL-4 gene has mono and bi-allelic expression and is located in a region of 140kb on chromosome 5q31-33 that codes for a cluster of TH2 type cytokines [9] [10] [11] . Polymorphisms in the regulatory regions of cytokine genes can influence the amount of cytokine produced. These segregate independently so that each person has an individual profile of high and lower cytokine response. Homozygous TT individuals for the +33C/T SNP in IL-4 are high IL-4 producers while CC are low IL-4 producers 12 . Clinical manifestations of MS might be related to genetically-determined aberrant IL-4 and IL4R cytokine gene expression 13, 14 . Interleukin polymorphisms that affect expression or function of cytokines in a particular population may contribute to understand the susceptibility and pathogenesis of inflammatory diseases 15, 16 . In this context it was important to determine whether previously described polymorphisms in the IL-4 and IL4R genes 13, 17, 18 were also associated to MS in south-eastern Brazilians that share genetic similarity with European Caucasians analysis of the chi-square frequencies. Each SNP was analysed against its effect on known patient clinical parameters and compared with controls. Uncorrected probability values less than or equal to 0.05 were taken to be statistically significant.
RESULTS
There were no significant differences in allele count, carriage rate and genotype frequencies for the +33 (CT) polymorphism in the promoter region of the IL4 gene and the Q551R polymorphism in the receptor IL4R alpha chain between healthy individuals and MS patients (Table 1) . Although the differences were not considered statistically significant, genotyping of +33 (C to T) SNP showed a slight decrease in homozygous TT (MS=4.6%; controls= 6.7%) genotypes in conjunction with a small increase of the CT genotype in the MS population (41.1 vs 37.4%) compared with controls. Likewise, MS patients also showed increased percentage (12.5%) of CC allele Q551R genotype for IL4R than corresponding controls (8.1%).
It was therefore important to verify whether such differences among MS patients would be strengthened if ethnicity and gender were considered during analysis. Indeed, results in Table 2 . Indeed, comparison of the male patient strata between both ethnic groups did not reveal any difference. Concomitantly, the IL4R allele frequency was significantly different between female CA-MS and AF-MS patients (p=0.016) but not between the male CA and AF-MS patients. Considering that IL4 +33 T allele occurrence is not very common, it is noteworthy that both female and male AF-MS patients showed higher TT genotype percentage than corresponding CA-MS. Further stratification according to gender was considered unlikely to be informative due to low number of IL4 TT homozygous. Still, a trend toward under representation of the TT genotype in male CA-MS compared to AF-MS patients was seen (χ 2 =3.14; p=0.08). A similar pattern was also observed for IL4RA genotype with African descendants showing a consistent increase in CC genotypes than CA-MS patients. Within each ethnic group no significant differences were found for comparison between male and female MS patients for IL4 and IL4R.
DISCUSSION
Three widely typed markers in the gene encoding the TH2 cytokine IL-4, the promoter region P (*523 C or T); the exon E1 (*+33C or T) and variable tandem repeats VNTR in the third intron I3, combine to form two major haplotypes related to high (type I) or low (type II) IL-4 producers 14 . The occurrence of type I haplotype in TH1-mediated inflammatory diseases is associated with increased IL-4 production, less severe clinical course and late onset 18 . Brazilian Although the numbers of patients and controls included in this case-control study were low, the genotype frequencies of healthy control subjects are representative of the general Brazilian population of the southeast. It is conceivable that lack of association of IL4 +33 (C to T) and IL4R (T to C) polymorphisms may reflect genetic heterogeneity in the pathogenesis of the disease among different ethnicities or to difference on the type/amount of exposure to environmental factors 4, 11 . The data show that neither IL4 nor IL4R genes are susceptibility factors for MS but may be able to modify ethnicity-dependent disease risk and penetrance of susceptibility factors. Collectively, it would be interesting to verify whether MS as currently seen in Brazilian -African people is likely to follow a TH2 kind of inflammation rather than TH1 such as in Caucasians. The Western phenotype of MS was recently proposed to have emerged because of TH2 to TH1 switching of the original optic neuromyelitis immune response during transgression into relapsing-remitting MS 24, 25 . Interestingly, Brazilian AF-MS patients developing opticospinal MS and transverse myelitis have a more aggressive disease course and higher mortality than CA-MS patients 3, 26 . Knowledge of polymorphisms influencing the balance of cytokine signalling and the outcome of MS in a population with high degree of racial admixture may prove useful in prediction of customized immunotherapy.
